Screening and rank ordering of reversible mechanism‐based inhibitors of Hepatitis C virus NS3 protease using electrospray ionization mass spectrometry
Yan‐Hui Liu(Hainan University), Birendra N. Pramanik, Tin‐Yau Chan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lata Ramanathan(AGCO (United Kingdom)), George Njoroge(Merck & Co., Inc., Rahway, NJ, USA (United States)), Bruce A. Malcolm(Janssen (Belgium))
Cited by 2
Related Papers
Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor Cells
|Clinical Cancer Research|2017|136
PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer
|International Journal of Oncology|2015|131
Catalytic Activity of Human ADAM33
|Journal of Biological Chemistry|2004|117
Overexpression of eIF5A‐2 is an adverse prognostic marker of survival in stage I non–small cell lung cancer patients
|International Journal of Cancer|2010|95